Cart (0 Items)
Your cart is currently empty.
View ProductsAIxplore®, your AI Antibody Design Platform
Bring your antibody to the clinic faster with our proprietary AI models.
0 weeks
From sequence to optimized antibody
Up to 0%
Faster timelines compared to conventional workflows
0%
IP-free results
0Bn
Sequences in our proprietary models
Discover AIxplore® : 4 AI platforms to move your antibody toward the clinic
Epitope Mapping
Precisely identify the amino acids involved in the antibody–antigen interaction.
Ideal for patent filing, mechanism-of-action understanding, and guiding future optimization steps.
Affinity Maturation
Enhance antibody affinity and specificity while preserving stability and developability.
Humanization / specization
Prepare your antibody for clinical development by minimizing immunogenicity while maintaining binding performance. Specization is also possible, especially for veterinary antibody development.
Developability optimization
Select variants optimized for expression, stability, and manufacturability, helping to reduce production costs early on.
The result: a fully optimized AI antibody designed to progress in the pipeline
By combining our platforms, you obtain antibodies with: verified binding mechanisms, enhanced affinity and specificity, robust expression and stability, minimal immunogenicity risk
In short: antibodies designed not only to bind, but to progress in the pipeline.
Built by biologists, for biologists
Our AI models were designed with one clear objective: be useful at the bench.
They are not black boxes that simply output an optimized sequence. Instead, they generate scientifically interpretable results that help you understand your antibody and its interaction with the antigen.
Combined with the expertise of our scientists, this interpretability enables the selection of biologically relevant variants that AI alone could not reliably identify.
Save weeks of development time
Our AI platforms consistently shorten development timelines by up to 80% compared to traditional approaches. This acceleration is achieved through a comprehensive multi-parameter scoring system that evaluates stability, aggregation risk, expression potential, and more. Innovation is not about replacing biology with algorithms, it is about accelerating the right decisions with the right data.
The result? Better candidates, selected earlier, and more informed decision-making than with conventional workflows.
Case report: Discover a real epitope mapping project performed by ProteoGenix, from AI prediction to experimental validation.
Read our case report
Antibodies that perform in the real world
Our strength lies in the tight integration of AI and wet lab validation.
Predicted variants are experimentally tested, and the resulting data are reinjected into our models for successive AI/wet lab optimization rounds.
This iterative approach ensures antibodies that perform not only in silico, but also in your laboratory.
